Results 31 to 40 of about 2,350,568 (218)

Combination therapies in psoriasis

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Topical corticosteroids and vitamin D analogs can be combined with other topical, systemic, and biological agents. The effect of methotrexate can be enhanced with ultraviolet B (UVB) or psoralen ultraviolet A (PUVA).
Erol Koç, Emel Bülbül Başkan
doaj   +1 more source

Accidental PUVA burns, vitiligo and atopic diathesis resulting in prurigo nodularis: a logical but undocumented rarity Prurigo nodular induzido por queimaduras acidentais por PUVA, vitiligo e diátese atópica: uma raridade lógica, mas não documentada

open access: yesAnais Brasileiros de Dermatologia, 2012
Vitiligo is a dreaded disease in India due to its social and cultural consequences. PUVA and PUVAsol are the main treatment modalities for vitiligo vulgaris.
Shyam Bhanushankar Verma, Uwe Wollina
doaj   +1 more source

PUVA therapy for photosensitive psoriasis

open access: yesActa Dermato-Venereologica, 1987
The purpose of this study was to assess the prophylactic effect of oral photochemotherapy with psoralens and UVA (PUVA) on patients with light-sensitive psoriasis. Of fifteen patients with photosensitive psoriasis, ten with a history of polymorphous light eruption (PMLE) slowly developing into psoriasis were treated with trimethylpsoralen (TMP) and UVA.
A M, Ros, G, Wennersten
openaire   +2 more sources

Phothotherapy of skin diseases: timeless classics

open access: yesКлинический разбор в общей медицине, 2023
The review paper provides brief analysis of phototherapy methods used in various dermatoses. Phototherapy can be prescribed in combination with drugs or used solo.
Mariya V. Kail-Goryachkina
doaj   +1 more source

6-Thioguanine Resistant Peripheral Blood Lymphocytes in Humans Following Psoralen, Long-Wave Ultraviolet Light (PUVA) Therapy [PDF]

open access: yes, 1979
A recently described method that enumerates variant 6-thioguanine resistant peripheral blood lymphocytes present in vivo in man as a potential marker of somatic cell mutations occurring in vivo was used to study 18 psoriatic patients receiving PUVA ...
Krusinski, Paul A.   +3 more
core   +1 more source

Phototherapy as a First Line Treatment for Mycosis Fungoides: A 10-year Retrospective Study

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2019
Introduction: Phototherapy, particularly psoralen plus ultraviolet A (PUVA) and narrowband ultraviolet B (nbUVB), is a mainstay in the treatment of Mycosis Fungoides (MF).
Alexandra Azevedo   +5 more
doaj   +1 more source

Phototherapy

open access: yesAnais Brasileiros de Dermatologia, 2021
Of all the therapeutic options available in Dermatology, few of them have the history, effectiveness, and safety of phototherapy. Heliotherapy, NB-UVB, PUVA, and UVA1 are currently the most common types of phototherapy used.
Norami de Moura Barros   +5 more
doaj   +1 more source

Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007

open access: yesIndian Journal of Dermatology, 2014
Background: Systemic oral psoralens plus UVA therapy (PUVA) is a therapeutic method used with considerable success in many different skin disorders. PUVA therapy causes some cutaneous and noncutaneous side effects and in the present research we deal with
Masoud Maleki   +3 more
doaj   +1 more source

Shower-PUVA : an innovative method for local PUVA therapy. Clinical and pharmacokinetic results with psoriasis vulgaris

open access: yes, 2002
TITELBLATT 1. EINLEITUNG 1 1.1. Psoriasis vulgaris 1 1.2. Biologische Wirkung des Lichtes 11 1.3. Psoralene  14 1.4. Untersuchungsgegenstand  41 2. PATIENTEN, MATERIAL UND METHODEN  43 2.1. Klinische Studie: Dusch-PUVA vs.
Aryee-Boi, Jeannette
core   +1 more source

Efficacy, Safety, and Maintenance Use of Topical Bexarotene in Early‐Stage Mycosis Fungoides: A Single‐Center Retrospective Real‐World Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Topical bexarotene 1% gel is an approved skin‐directed treatment for refractory or persistent stage IA‐IB cutaneous T‐cell lymphoma, but real‐world evidence in mycosis fungoides (MF), particularly regarding maintenance use after complete response, remains limited.
Fatich Memet   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy